Prime Medicine Inc (PRME)
7.085
+0.04
(+0.64%)
USD |
NASDAQ |
May 17, 16:00
7.085
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine 1 Year Total Returns (Daily): -45.62% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -45.62% |
May 16, 2024 | -43.95% |
May 15, 2024 | -47.60% |
May 14, 2024 | -47.64% |
May 13, 2024 | -49.53% |
May 10, 2024 | -60.04% |
May 09, 2024 | -59.26% |
May 08, 2024 | -62.17% |
May 07, 2024 | -61.10% |
May 06, 2024 | -62.29% |
May 03, 2024 | -61.13% |
May 02, 2024 | -59.20% |
May 01, 2024 | -62.38% |
April 30, 2024 | -64.27% |
April 29, 2024 | -64.71% |
April 26, 2024 | -66.58% |
April 25, 2024 | -66.64% |
April 24, 2024 | -64.09% |
April 23, 2024 | -64.10% |
April 22, 2024 | -64.25% |
April 19, 2024 | -67.32% |
April 18, 2024 | -66.32% |
April 17, 2024 | -63.02% |
April 16, 2024 | -60.64% |
April 15, 2024 | -59.37% |
Date | Value |
---|---|
April 12, 2024 | -54.67% |
April 11, 2024 | -54.96% |
April 10, 2024 | -52.11% |
April 09, 2024 | -48.41% |
April 08, 2024 | -49.08% |
April 05, 2024 | -49.61% |
April 04, 2024 | -50.26% |
April 03, 2024 | -51.63% |
April 02, 2024 | -48.62% |
April 01, 2024 | -45.04% |
March 28, 2024 | -41.13% |
March 27, 2024 | -43.05% |
March 26, 2024 | -40.59% |
March 25, 2024 | -38.72% |
March 22, 2024 | -44.11% |
March 21, 2024 | -44.73% |
March 20, 2024 | -42.87% |
March 19, 2024 | -42.15% |
March 18, 2024 | -42.88% |
March 15, 2024 | -44.84% |
March 14, 2024 | -49.11% |
March 13, 2024 | -44.08% |
March 12, 2024 | -44.33% |
March 11, 2024 | -42.02% |
March 08, 2024 | -47.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-69.60%
Minimum
Nov 01 2023
-38.72%
Maximum
Mar 25 2024
-55.43%
Average
-55.30%
Median
Dec 29 2023
1 Year Total Returns (Daily) Benchmarks
Pacific Biosciences of California Inc | -84.16% |
10x Genomics Inc | -52.40% |
Recursion Pharmaceuticals Inc | 75.09% |
Verve Therapeutics Inc | -65.11% |
Ginkgo Bioworks Holdings Inc | -36.57% |